Aqua Bio Technology - Director's Dealing 2026

Aqua Bio Technology ASA: Primary insider notification

Reference is made to the stock exchange notice from Aqua Bio Technology ASA

("ABTEC" or the "Company") published on 13 March 2026 regarding the

Extraordinary General Meeting approving a NOK 50 million debt conversion with

the issuance of 10,000,000 new shares (the "New Shares") in the Company, at a

subscription price of NOK 5.00 per New Share (the "Debt Conversion").

Expo Holding AS, a close associate of ABTEC board member Tonje Blaker, has

subscribed for and been allocated 1,891,892 New Shares in the Debt Conversion.

Following this and upon completion of the Debt Conversion, Expo Holding AS

holds 2,156,763 shares in the Company.

Please see the attached notification form for further information.

This information is subject to the disclosure requirements pursuant to MAR

article 19.

Contacts

Kristian Flaten

CEO & CFO

Aqua Bio Technology ASA

Phone: +47 9509 2322

About Us

Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in

skincare and nonfood. The group has distribution towards B2C and B2B, and

offers freight, customs, and logistics services. The group also develops

sustainable biotechnology for use in skincare products. Aqua Bio Technology is

listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act §

5-12 and MAR. The information was submitted for publication, through the

agency of the contact persons set out above, at 2026-03-16 23:33 CET.

AI assistant